Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis

References

• Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DRJr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011. Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 43:1575–1581.
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine. 2006. Guidelines for exercise testing and prescription. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Antoniou KM, Tzanakis N, Tzouvelekis A, Samiou M, Symvoulakis EK, Siafakas NM, Bouros D. 2006. Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med. 17:421–426.
   PubMed Web of Science ®Google Scholar
• Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Buyukoglan H, Kalay N, Kanbay A, Zencir C, Ergin A.. 2011. Impaired heart rate recovery index in patients with sarcoidosis. Chest. 139:60–68.
   PubMed Web of Science ®Google Scholar
• Balamugesh T, Behera D, Bhatnagar A, Majumdar S. 2006. Inflammatory cytokine levels in induced sputum and bronchoalveolar lavage fluid in pulmonary sarcoidosis. Indian J Chest Dis Allied Sci. 48:177–181.
   PubMedGoogle Scholar
• Bansal AS, Bruce J, Hogan PG, Allen RK. 1997. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23. Clin Exp Immunol. 110:92–97.
   PubMed Web of Science ®Google Scholar
• Buske-Kirschbaum A, Ebrecht M, Hellhammer DH. 2010. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun. 24:1347–1353.
   PubMed Web of Science ®Google Scholar
• Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. 1992. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1281–1288.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL. 1997. Circadian relationships between interleukin (IL)-6 and hypothalamic–pituitary–adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 82:1279–1283.
   PubMed Web of Science ®Google Scholar
• DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM. 1997. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: High sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab. 82:2182–2191.
   PubMed Web of Science ®Google Scholar
• Deuster PA, Petrides JS, Singh A, Chrousos GP, Poth M. 2000. Endocrine response to high-intensity exercise: Dose-dependent effects of dexamethasone. J Clin Endocrinol Metab. 85:1066–1073.
   PubMed Web of Science ®Google Scholar
• Dubaniewicz A. 2010. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev. 9:419–424.
   PubMed Web of Science ®Google Scholar
• Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C. 2011. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 66:144–150.
   PubMed Web of Science ®Google Scholar
• Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. 1993. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic–pituitary–adrenal axis in patients with Cushing syndrome. J Clin Endocrinol Metab. 77:173–177.
   PubMed Web of Science ®Google Scholar
• Guntupova LD, Borisov SE, Kupavtseva EA, Mikhaîlova LP, Makarova OV. 2006. The cytokine profile in granulomatous lung diseases. Probl Tuberk Bolezn Legk. 6:10–14 (Article in Russian).
   Google Scholar
• Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MAJr, Cerami A, Shires GT, Lowry SF. 1988. Cytokine appearance in human and endotoxemia and primate bacteremia. Surg Gynecol Obset. 166:147–153.
   PubMedGoogle Scholar
• Hunninghake GW. 1984. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Resp Dis. 129:569–572.
   PubMed Web of Science ®Google Scholar
• Iannuzzi MC, Rybicki BA, Teirstein AS. 2007. Sarcoidosis. N Engl J Med. 357:2153–2165.
   PubMed Web of Science ®Google Scholar
• Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. 1998. Hypofunction of the stress axis in Sjogren's syndrome. J Rheumatol. 25:1508–1514.
   PubMed Web of Science ®Google Scholar
• Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP. 1987. Acute hypothalamic–pituitary–adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med. 316:1309–1315.
   PubMed Web of Science ®Google Scholar
• Maniwa K, Ogushi F, Haku T, Sone S, Ohmoto Y. 1998. Sarcoidosis associated with acute renal failure and increased levels of interleukin-6 in urine. Intern Med. 37:757–761.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Chrousos GP, Weber JS. 1993. Recombinant interleukin-6 activates the hypothalamic–pituitary–adrenal axis in humans. J Endocrinol Metab. 77:1690–1694.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Ilias I. 2000. Relationship between interleukin-6 (IL-6) and hypothalamic–pituitary–adrenal axis hormones in rheumatoid arthritis. Z Rheumatol. 59:75–79.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Pavlatou M. 2005. Exercise as a stress model and the interplay between the hypothalamus–pituitary–adrenal and the hypothalamus–pituitary–thyroid axes. Horm Metab Res. 37:577–584.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP. 2005. Exercise and the stress system. Hormones (Athens). 4:73–89.
   PubMedGoogle Scholar
• Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 317:256–260.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Finotto S. 2011. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 22:83–89.
   PubMed Web of Science ®Google Scholar
• Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK. 1998. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (Lond). 513:889–894.
   Google Scholar
• Papanicolaou DA, Petrides JS, Tsigos C, Bino S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP. 1996. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol. 271:E601–E605.
   PubMed Web of Science ®Google Scholar
• Päth G, Scherbaum WA, Bornstein SR. 2000. The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest. 30:91–95.
   PubMed Web of Science ®Google Scholar
• Pedersen BK. 2009. Edward F. Adolph distinguished lecture: Muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol. 107:1006–1014.
   PubMed Web of Science ®Google Scholar
• Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SB, Hunninghake GW. 1993. The relationship between alveolar-macrophage TNF, IL-1 and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest. 103:832–838.
   PubMed Web of Science ®Google Scholar
• Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, Siekmann L, Vollmer D, Winkelmann W, Chrousos GP. 1994. Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African Trypanosomiasis. Neuroimmunomodulation. 1:14–22.
   PubMedGoogle Scholar
• Sahashi K, Ina Y, Takada K, Sato T, Yamamoto M, Morishita M. 1991. Significance of interleukin 6 in patients with sarcoidosis. Chest. 106:156–160.
   Google Scholar
• Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. 1996. Interleukin 1 beta, tumor necrosis factor alpha, and inteleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: Potential mechanism of macrolide therapy. Respiration. 63:42–48.
   PubMed Web of Science ®Google Scholar
• Silver JS, Hunter CA. 2010. gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol. 88:1145–1156.
   PubMed Web of Science ®Google Scholar
• Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein SR, Stromeyer P, Drechsler S, Fehm HL, Porzsolt F. 1994. Interleukin-6 stimulates the hypothalamus–pituitary–adrenocortiscal axis in man. J Clin Endocrinol Metab. 79:1212–1214.
   PubMed Web of Science ®Google Scholar
• Steffen M, Petersen J, Oldings M, Karmeier A, Magnussen H, Thile HG, Reedler A. 1993. Increased secretion of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol. 91:939–949.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. 2002. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev. 8:6–48.
   PubMed Web of Science ®Google Scholar
• Takizawa H, Satoh M, Okazaki H, Matsuzaki G, Suzuki N, Ishii A, Suko M, Okudaira H, Morita Y, Ito K. 1997. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters. Clin Exp Immunol. 107:175–181.
   PubMed Web of Science ®Google Scholar
• Tzioufas AG, Tsonis J, Moutsopoulos HM. 2008. Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation.. 15:37–45.
   PubMed Web of Science ®Google Scholar
• Ullum H, Haahr PM, Diamant M, Palmo J, Halkjaer-Kristensen J, Pedersen BK. 1994. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol. 77:93–97.
   PubMed Web of Science ®Google Scholar
• Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH. 2000. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepindrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 27:911–918.
   PubMed Web of Science ®Google Scholar
• Zissel G, Prasse A, Müller-Quernheim J. 2010. Immunologic response to sarcoidosis. Semin Respir Crit Care Med.. 31:390–403.
   PubMed Web of Science ®Google Scholar